DeepHeme, a high-performance, generalizable deep ensemble for bone marrow morphometry and hematologic diagnosis
Shenghuan Sun(Gladstone Institutes), Gregory M. Goldgof(Memorial Sloan Kettering Cancer Center), Fabienne Lucas(Brigham and Women's Hospital), Zhanghan Yin(Memorial Sloan Kettering Cancer Center), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Iain Carmichael, Laura Brown(University of California San Francisco Medical Center), Roni Shouval(Memorial Sloan Kettering Cancer Center), Jacob D. Spector(University of California, San Francisco), Atul J. Butte(University of California, San Francisco), Rohan Sardana(Memorial Sloan Kettering Cancer Center), Jeeyeon Baik, Leonardo Boiocchi(University of Milan), Chuanyi M. Lu(San Francisco VA Health Care System), Dmitry B. Goldgof(University of South Florida), Orly Ardon(Memorial Sloan Kettering Cancer Center), Khawaja Hasan Bilal(Memorial Sloan Kettering Cancer Center), Sonam Prakash(University of California, San Francisco), Mikhail Roshal(Memorial Sloan Kettering Cancer Center), Dylan C. Webb(Memorial Sloan Kettering Cancer Center), Mariko Yabe(Memorial Sloan Kettering Cancer Center), Chad Vanderbilt(Memorial Sloan Kettering Cancer Center), Linlin Wang(University of California, San Francisco), Menglei Zhu, Siddharth Singi(Memorial Sloan Kettering Cancer Center), B. M. FRIED(Memorial Sloan Kettering Cancer Center), Ethan Yan(Memorial Sloan Kettering Cancer Center), Aijazuddin Syed(Memorial Sloan Kettering Cancer Center), Jacob Van Cleave(Memorial Sloan Kettering Cancer Center), Irem Isgor(Memorial Sloan Kettering Cancer Center)
Cited by 8
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Systematic pan-cancer analysis of tumour purity
|Nature Communications|2015|1.3k
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
|Proceedings of the National Academy of Sciences|2012|990
Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes
|Cell stem cell|2017|851
Cancer therapy shapes the fitness landscape of clonal hematopoiesis
|Nature Genetics|2020|739